REPLY: Thank you for allowing us to respond to Drs. Adams and Kwee, who caution readers about the utility of 18F-FDG in this letter, as they have done in many others (1–6). We thank them for their comments on our article (7) and appreciate their perspective on 18F-FDG, which, though imperfect, remains internationally regarded as the functional imaging agent of choice for patients with lymphoma.
Footnotes
Published online Apr. 27, 2017.
- © 2017 by the Society of Nuclear Medicine and Molecular Imaging.
REFERENCES
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
- 7.